Multiplexed LNP-mRNA Vaccination against Pathogenic Coronavirus Species

Investigators developed prototype LNP-mRNA vaccine candidates against SARS-CoV-2 Delta, SARS-CoV, and MERS-CoV, and tested how multiplexing LNP-mRNAs could induce effective immune responses in animal models.